Allena Pharmaceuticals, Inc. (24) | Transition Agreements (2)
- Transition Agreement, dated March 31, 2021, by and between Allena Pharmaceuticals, Inc. and Edward Wholihan (Filed With SEC on April 2, 2021)
- Transition Agreement, dated January 4, 2019 by and between Allena Pharmaceuticals, Inc. and Alexey Margolin, Ph.D (Filed With SEC on January 4, 2019)
